TradingHolo

The whole market. One view. Market data from our own platform. Not investment advice. Prices in listing currency with AED alongside; market cap in USD. Live = streaming now; Delayed 15 min where the exchange requires it; At close = last official close.

News Calendar Economy IPOs ETFs Account

⌂Home ◈Markets ▦Screener 📈Tools ◎Portfolio

Skip to content

DFM General5,851.39−0.27%FTSE ADX9,783.24−0.26%TASI10,123.62−0.65%QE Index8,632.66−0.01%S&P 5007,659.44−1.09%Nasdaq 10029,187.55−2.50%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,966.09−0.27%DFM:EMIRATESNBDAED 31.50−0.25%ADX:IHCAED 352.00−0.17%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.66+2.29%NAS:NVDA$216.06+0.90%NYSE:TSM$419.10+1.57%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 299.47+0.12%Gold$4,165.99+0.01%Brent$107.64−1.98%BTC$82,313.48+0.36%ETH$2,414.85+0.31%DFM General5,851.39−0.27%FTSE ADX9,783.24−0.26%TASI10,123.62−0.65%QE Index8,632.66−0.01%S&P 5007,659.44−1.09%Nasdaq 10029,187.55−2.50%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,966.09−0.27%DFM:EMIRATESNBDAED 31.50−0.25%ADX:IHCAED 352.00−0.17%SAU:2222SAR 25.80+0.00%DSMD:QNBKQAR 15.66+2.29%NAS:NVDA$216.06+0.90%NYSE:TSM$419.10+1.57%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 299.47+0.12%Gold$4,165.99+0.01%Brent$107.64−1.98%BTC$82,313.48+0.36%ETH$2,414.85+0.31%

Stock markets

🇦🇪UAEDFM · ADX · DFM GeneralClosed 🇸🇦Saudi ArabiaTadawul · TASIClosed 🇶🇦QatarQSE · QE GeneralClosed 🇺🇸United StatesNasdaq · NYSE · S&P 500Open 🇮🇳IndiaNSE · BSE · Nifty 50Closed 🇵🇰PakistanPSX · KSE-100Closed

Other assets

₿CryptoRanked by volume · 24/7 🥇Gold, FX & economyDubai gold, AED crosses, rates ◫ETFsIndex, sector and gold funds

Explore

▦Market mapEvery market as a heatmap 📅Calendar & IPOsEarnings, dividends, listings, releases ⌁Options flow · Ownership · PoliticsUS filings and tapes

⚲Stock screenerAll six markets, one row per company ★Ready-made screensStarting points with a point of view 📁My saved screensSaved rules with alerts on new matches ⇄CompareUp to five, side by side

📈ChartingDrawings, indicators, replay ▶Strategy MakerWrite a rule, test it on history ⇄CompareSide by side 🔔AlertsPrice, earnings, screens, strategies

⌕

Sign in Create account👤

Royalty Pharma PLC · Overview · TradingHolo

Markets › United States › NAS › RPRX

R

Royalty Pharma PLC

NAS:RPRXHealthcareNASDAQ:NBISTOXX:EDD24BP

$60.96+2.25%At closeAt close · Sat 17 Oct · ≈ AED 223.88 · Market cap $35.06B · Next earnings Wed 4 Nov

🔔 Alert▶ Test a strategy

Overview Chart Financials Valuation Forecasts Dividends Ownership Options Shorts News Profile

1D

+2.3%

1M

+3.4%

3M

+6.4%

6M

+21.9%

1Y

+68.5%

Why it's moving today

No company news in the last day; the move tracks its market and sector.

RPRX +2.25% today

✦ This week in three lines

No written digest yet for RPRX. The figures on this page are the source when one is written.

Financials

USD billions · annual5Y CAGR +2.3%

Valuation

P/E vs sector45.5× vs −1.7×

Price / Book vs sector3.6× vs 2.0×

Price / Sales vs sector14.7× vs 3.9×

Price / Free cash flow vs sector14.1× vs −1.6×

cheap for itself (10.4×)expensive for itself (33.2×)

Forecasts

8 buy2 hold0 sell10 analysts

Average target$65.50 +7.4%

Analysts2

EPS surprises, last 87 beats

Dividends

Yield1.1%

Annual payout$0.9250

Payout ratio49.1%

Next ex-dateFri 13 Nov

Years of growth5

Latest news

All RPRX news →

SEGoldman's defensive stocks with quality-growth characteristics

Seeking Alpha · 22 h ago

SERoyalty Pharma declares $0.235 dividend

Seeking Alpha · 3 d ago

TRRoyalty Pharma plc (RPRX) Declares $0.235 Q4 Dividend

TradingView · 3 d ago

Key facts

At close · Sat 17 Oct

Market cap (USD)$35.06B

P/E45.5×

Dividend yield1.1%

52-week range$35.87 – $64.38

Avg volume (20d)3,017,794

Shares outstanding445,277,000

Beta0.42

Short interest3.1% of float

Next earningsWed 4 Nov

Radar Score

78

Value45

Quality91

Momentum80

Income95

Peer percentile within United States Healthcare0–100 · null when more than one input is missing

About

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as…

SectorHealthcare

IndustryNormal

ExchangeNAS

Peers

LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE

57.3×+0.43%

JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE

23.0×+0.90%

ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE

119.3×+0.71%

UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE

29.9×−1.29%